<p>Effectiveness of the monovalent XBB.1.5 COVID-19 vaccines against hospitalisation among individuals aged ≥65 years old<sup>a</sup>, by VSL (XBB or BA.2.86) and by time since vaccination (TSV), using four modelling approaches: sequence data (SD), standard predominance period approach (PP), adapted predominance period with VSL categorical variable approach (VCM) and with VSL proportion variable approach (VPM). VEBIS hospital network, Europe, 2023/24.</p>
收藏NIAID Data Ecosystem2026-05-10 收录
数据链接：
官方服务：
资源简介：
Effectiveness of the monovalent XBB.1.5 COVID-19 vaccines against hospitalisation among individuals aged ≥65 years olda, by VSL (XBB or BA.2.86) and by time since vaccination (TSV), using four modelling approaches: sequence data (SD), standard predominance period approach (PP), adapted predominance period with VSL categorical variable approach (VCM) and with VSL proportion variable approach (VPM). VEBIS hospital network, Europe, 2023/24.
创建时间：
2026-03-09
